DUBLIN, Jan. 26, 2024 /PRNewswire/ — The “Global Virtual Reality Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. The global virtual reality market is projected to…
Month: January 2024
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Expensify, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 29, 2024 – (NASDAQ: EXFY)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Expensify, Inc.. Shareholders who purchased shares of EXFY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of VNET Group, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 26, 2024 – (NASDAQ: VNET)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of VNET Group, Inc.. Shareholders who purchased shares of VNET during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Dada Nexus Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 11, 2024 – (NASDAQ: DADA)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Dada Nexus Limited. Shareholders who purchased shares of DADA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Assertio Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 5, 2024 – (NASDAQ: ASRT)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Assertio Holdings, Inc.. Shareholders who purchased shares of ASRT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 – (NASDAQ: BIVI)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of BioVie Inc.. Shareholders who purchased shares of BIVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Mobileye Global Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 18, 2024 – (NASDAQ: MBLY)
NEW YORK, Jan. 26, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Mobileye Global Inc.. Shareholders who purchased shares of MBLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
Critical Path Institute ernennt Dr. Klaus Romero zum neuen CEO und befördert Cécile Ollivier zur Vizepräsidentin für globale Angelegenheiten
AMSTERDAM, 26. Januar 2024 /PRNewswire/ — Das Critical Path Institute (C-Path) hat Dr. Klaus Romero, M.D., M.S., FCP, zu seinem neuen geschäftsführenden Direktor ernannt und Cécile Ollivier, M.S., von Managing-Direktorin, Europa, zur Vizepräsidentin für globale Angelegenheiten befördert….
Critical Path Institute – новые CEO и вице-президент по международным вопросам
Critical Path Institute назначает д-ра Клауса Ромеро (Klaus Romero) новым главным исполнительным директором, а Сесиль Олливьер (Cécile Ollivier) становится вице-президентом по международным вопросам. АМСТЕРДАМ, 26 января 2024 г. /PRNewswire/ — Институт Critical Path Institute (C-Path)…
Critical Path Institute mianuje dr Klausa Romero nowym dyrektorem generalnym i awansuje Cécile Ollivier na stanowisko wiceprezesa ds. globalnych
AMSTERDAM, 26 stycznia 2024 r. /PRNewswire/ — Organizacja Critical Path Institute (C-Path) mianowała dr Klausa Romero, członka Kolegium Farmakologii Klinicznej, nowym dyrektorem generalnym i awansowała Cécile Ollivier z funkcji dyrektora zarządzającego w Europie na wiceprezesa ds….
